Elevance Health (ELV) Proxy filing summary

Executive summary

• Annual Meeting of Shareholders scheduled for May 13, 2026, at 8:00 a.m. Eastern Time, to be held virtually via live audio webcast.

• Shareholders can participate, vote, submit questions, and view the list of shareholders of record during the meeting.

• Proxy materials, including the Notice of Annual Meeting, Proxy Statement, and 2025 Annual Report on Form 10-K, are available online.

Voting matters and shareholder proposals

• Election of three directors: Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable.

• Advisory vote to approve the compensation of named executive officers (Say-on-Pay).

• Ratification of Ernst & Young LLP as auditors for 2026.

• Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups, with Board recommending a vote against.

• Proxies may vote on other business that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for Proposals 2 and 3, and against Proposal 4.